the"Fuzheng" Therapy of TCM to Improve the Survival Quality of Early-stage NSCLC by Intervening the CTCs
Status:
Completed
Trial end date:
2019-09-01
Target enrollment:
Participant gender:
Summary
Metastasis is the leading cause of death in patients with lung cancer, and circulating tumor
cells(CTCs) play a key role in the process of distant metastasis. The investigators' study
will elaborate the clinical significance of CTCs intervented by Traditional Chinese
Medicine(TCM) in lung cancer from the diagnosis and clinical staging,metastasis and
recurrence, individual treatment and prognosis and so on, in order to provide a new direction
for the treatment of lung cancer.
Phase:
Phase 1
Details
Lead Sponsor:
Shanghai University of Traditional Chinese Medicine